Severe asthma in the era of COVID-19

Funding Information: João Gaspar Marques has received research grants from AstraZeneca and honorarium as speaker/consultant from AstraZeneca, Novartis, Sanofi and TEVA. Mafalda van Zeller has received honorarium as speaker/consultant from AstraZeneca, GlaxoSmithKline, Novartis and TEVA. Pedro Carrei...

ver descrição completa

Detalhes bibliográficos
Autor principal: Gaspar-Marques, João (author)
Outros Autores: van Zeller, Mafalda (author), Carreiro-Martins, Pedro (author), Chaves Loureiro, Cláudia (author)
Formato: review
Idioma:eng
Publicado em: 2021
Assuntos:
Antibodies
Asthma
Covid-19
Monoclonal
SARS-CoV-2
Pulmonary and Respiratory Medicine
Texto completo:http://hdl.handle.net/10362/119322
País:Portugal
Oai:oai:run.unl.pt:10362/119322

Texto Completo

http://hdl.handle.net/10362/119322

Registros relacionados